The agent is the compound 3-2-[4-(6-fluoro-benzo[d]isoxazol-3-il)-3,6-dihydro-2H-pyridin-1-il]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one having the formula (I) and pharmaceutically acceptable salts thereof; the process is based on the reduction of a selected pyridin salt by means of a metal borohydride; its preferred application is as an antipsychotic agent.
该制剂是具有式 (I) 的化合物 3-2-[4-(6-
氟-苯并[d]
异恶唑-3-il)-3,6-二氢-2H-
吡啶-1-il]-乙基}-2-甲基-6,7,8,9-四氢
吡啶并[1,2-a]
嘧啶-4-酮及其药学上可接受的盐类;该工艺基于通过
金属
硼氢化物还原所选的
吡啶盐;其首选应用是作为
抗精神病药物。